🔎 Trials Near Me

Beranda › Karsinoma Duktal In Situ (DCIS)

Uji klinis Karsinoma Duktal In Situ (DCIS) yang merekrut di AS

30 studi untuk Karsinoma Duktal In Situ (DCIS) merekrut peserta di lokasi di seluruh Amerika Serikat.

Kota dengan studi terbanyak

Berdasarkan negara bagian

Studi yang baru diperbarui

Teks studi resmi (Bahasa Inggris)

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 28 Sep 2026 · NCT06075953

CAN1012 in Pre-Malignant DCIS and LCIS

Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07408856

Personalized Prone Immobilization for Accelerated Partial Breast Radiotherapy

Menerima peserta
Usia 40 ke atas · Wanita · Diperbarui 23 Sep 2026 · NCT07711847

Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

Menerima pesertaSukarelawan sehat diterima
Usia 30 hingga 74 · Wanita · Diperbarui 21 Sep 2026 · NCT02620852

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Menerima pesertaFase 2
Usia 45 ke atas · Wanita · Diperbarui 21 Sep 2026 · NCT04084730

Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Menerima pesertaFase 1
Usia 18 ke atas · Wanita · Diperbarui 18 Agu 2026 · NCT06218303

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Menerima pesertaFase 2Sukarelawan sehat diterima
Usia 45 hingga 74 · Wanita · Diperbarui 4 Agu 2026 · NCT06195306

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Menerima pesertaFase 2
Usia 18 hingga 55 · Wanita · Diperbarui 27 Jul 2026 · NCT06184750

Identifying and Caring for Individuals With Inherited Cancer Syndrome

Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT04494945

Impact of Dietary Inflammatory Potential on Breast Cancer Risk

Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT05178498

Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer

Menerima pesertaFase 2
Usia 40 ke atas · Wanita · Diperbarui 11 Jun 2026 · NCT03936478

Impact of COVID-19 Pandemic on Out-of-Pocket Costs, Lost Wages, and Unemployment in Patients With Breast Cancer Undergoing Breast Surgery

Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 4 Mei 2026 · NCT04169542

The PREDICT Registry:

Menerima pesertaStudi observasional
Usia 30 hingga 85 · Wanita · Diperbarui 17 Apr 2026 · NCT03448926

EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients

Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 17 Mar 2026 · NCT07478016

Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma

Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 12 Mar 2026 · NCT03909282

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Menerima pesertaFase 1
Usia 18 ke atas · Wanita · Diperbarui 5 Mar 2026 · NCT04144023

A Patient Navigation Program for Addressing Disparities in Breast Cancer Care

Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 17 Feb 2026 · NCT06350500

Pre-operative SABR With and Without Caloric Restriction for Early Stage Breast Cancer

Menerima peserta
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 23 Jan 2026 · NCT04959474

5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer

Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 9 Des 2025 · NCT06961955

ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy

Menerima pesertaFase 2
Usia 45 hingga 79 · Wanita · Diperbarui 21 Nov 2025 · NCT06185205

A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.

Menerima peserta
Usia 18 ke atas · Wanita · Diperbarui 18 Sep 2025 · NCT07095114

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.